Volume 7, number 1
 Views: (Visited 136 times, 1 visits today)    PDF Downloads: 877

Kour P, Lal M, Panjaliya R, Dogra V, Gupta S. Study of the Chromosomal Changes in the Cervical Carcinoma. Biosci Biotech Res Asia 2010;7(1)
Manuscript received on : January 12, 2010
Manuscript accepted on : February 18, 2010
Published online on:  --
How to Cite    |   Publication History    |   PlumX Article Matrix

Study of the Chromosomal Changes in the Cervical Carcinoma

Parvinder Kour, Mohan Lal, rakesh Panjaliya, Vikas Dogra and Subash Gupta

Human genetic research cum counseling centre, department of zoology, university of Jammu, Jammu - 180 006 India.

Corresponding Author E-mail:parimanu@gmail.com

ABSTRACT: The present study, which was conducted in the Department of Gynecology and Obstetrics SMGS Hospital, Government Medical College, Jammu and Human Genetic Research cum Counselling Centre, University of Jammu, aimed at to analyze the chromosomal changes in fifty (50) cases of the cervical carcinoma by in vivo technique. Some non cytogenetic factors like age, early marriage, high parity, cigarette smoking, race and low socio-economic status which are considered as risk factors for cervical cancer were also studied. Both the numerical and structural chromosomal changes have been recorded in majority of these growths. In most of the cases numerical aberrations (95%) out numbered the structural aberrations. The numerical aberrations include aneuploidy and hyperdiploidy. Structural aberrations include translocations and deletions.

KEYWORDS:

Cervical carcinoma; aneuploidy; aberrations; parity.

Download this article as: 
Copy the following to cite this article:

Kour P, Lal M, Panjaliya R, Dogra V, Gupta S. Study of the Chromosomal Changes in the Cervical Carcinoma. Biosci Biotech Res Asia 2010;7(1)

Copy the following to cite this URL:

Kour P, Lal M, Panjaliya R, Dogra V, Gupta S. Study of the Chromosomal Changes in the Cervical Carcinoma. Biosci Biotech Res Asia 2010;7(1). Available from: https://www.biotech-asia.org/?p=9561

Introduction

Cervical carcinoma is one of the most common gynecologic malignancy world wide and a leading cause of death from genital malignancies. Approximately 5, 00,000 new cases of this cancer are diagnosed worldwide each year with the survival rate of only 40 % [1]. In the developing countries cervical carcinoma is ranked second with a relative frequency of 15% of all cancers in women, whereas in the developed countries this cancer is ranked fifth with a relative frequency of 4.4 % [2]. About 1/5 to 1/6 of the total incidence of cervical carcinoma in the world occurs in India [3]. In India, 365.71 million females above the age of 15 are at the risk of developing cervical cancer. It is estimated that about 132,082 women die due to cervical cancer every year, accounting for 26.7% of the world wide incidence. One woman in India die due to cervical cancer every 7 minutes accounting for more than 200 deaths every day The cumulative risk of the incidence of cervical cancer in women in India (age 0-64 yrs) is 2.4% compared to 1.3% for the world[ 4].

Epidemiological studies have shown the high risk Human PapillomaVirus (HPV) to be the most important risk factor and are present in 99.7% of the invasive cervical cancer worldwide [5]. Young age, early marriage, multiple sexual partners, poor genital hygiene, history of abortions, high parity, tobacco and oral contraceptive use,  cigarette smoking, race, low socio economic status have also been identified as significant risk factors for the development of CaCx [6].

Material and Methods

The present study was conducted in the Department of Gynecology and Obstetrics SMGS Hospital, Government Medical College, Jammu and Human Genetic Research cum Counselling Centre, University of Jammu. Cases were selected from patients having complains of excessive vaginal discharge, post coital bleeding, post menopausal bleeding etc. and on per speculum examination with suspected cervical  lesion or unhealthy cervix. Tissue pieces were transferred to the fresh hypotonic solution for 15 minutes at 370c. The material was fixed in methanol and acetic acid (3:1) and the slides were prepared by air drying method (Atkin and Baker, [7]). For conventional cytogenetic study, the prepared slides were subjected to GTG-Banding (Sea bright, [8]). The well spread G-banded metaphase plates were photographed and used for the preparation of their karyotypes. Besides chromosome study, non cytogenetic factors like marital age, religion, high parity etc. have also been studied in all 50 cases.

Observations

Well spread metaphase plates were selected for the preparation of their karyotypes to find out both the numerical and structural chromosomal abnormalities. Numerical chromosomal changes were more common as they were recorded in 95% of growths and structural chromosomal changes were observed in 5% of growths. . In the squamous cell carcinoma cases, aneuploidy was the commonest numerical chromosomal change. Besides aneuploidy, the micronuclei were also detected in both Squamous cell carcinoma and Adenocarcinoma. The frequency of micronuclei increased significantly in the Adenocarcinoma of the cervix. Chromosomal changes in the form of Trisomy 3, 8, 11, 12, 13, 17, 18, 19, 20, 21 and 22 were observed in squamous cell carcinoma. Monosomy of chromosome 3 was commonly seen in the adenocacinoma of the cervix.

Majority of the females in the present study belonged to age group of 50-69 yrs (Table 1). Incidence of CaCx was found to be common (68%) in the females who were Para three whereas 40% Para two (Table 2). According to the area distribution of these patients, 81.6% belonged to rural areas and only 18.4% belonged to urban area (Table 3). Incidence of CaCx was found to be higher in Hindus as compared to Muslims (Table 4).More than 58.3% of the females under study were married at the age of 21-25(Table 5). When ages at first issue of these patients were taken into consideration about 55% of the patients belonged to age group 19-22and 28.33% belonged to the age group 16-19 (Table 6).

Discussion

Different risk factors associated with the development of cervical carcinoma detected in the present study have been analyzed in detail. The findings are summarized below:

Maximum numbers of the patients (40%) were in the age group of 51-60 (Table 1). The present findings with respect to age were found consistent with the observations made by Spanos et al. [9], Parkin et al. [10], Miller [11] and Misra et al. [12].

Table 1: Patients belonging to different age group.

S. No. Age (in years) Number of patients Percentage frequency
1. 20-24 1 0.833%
2 25-29 3 2.5%
3 30-39 30 25.0%
4 40-49 24 20.0%
5 50-69 50 43.3%
6 70-79 1 0.833%
7 80-89 1 0.833%

Majority of the patients were multiparous (Table 2). Various workers like Wahi et al. [13], Brinton et al. [14], Aras and Pai [15] and Munoz et al. [16] also recorded a strong relationship of the risk of cervical carcinoma to the number of live births. Trauma to the cervix during delivery could be the possible explanations but alternative mechanisms that warrant exploration include increased susceptibility to infection through immunosuppression, hormonal influences and dietary deficiencies (Brinton et al. [14]).

Table 2: Relation of cervical cytopathologies with parity.

S. No Parity group Number of cases
1. Nulliparous 2
2. Para 1 10
3. Para 2 40
4. Para 3 and above 68

 

Maximum number of the patients in this study belonged to the rural areas (81.6%) and 18.4% belonged to urban areas (Table 3). Our findings were consistent with the reports of Coker et al. [18], Gajalakshmi and Shanta [19] that the incidence of cervical cancer is higher among the patients living in the rural areas. Since the recognized risk factors like illiteracy, low socioeconomic status early menarche, poor genital hygiene is widely prevalent in the rural population (Dutta et al. [20])

Table 3: Number of patients belonging to rural/urban background.

S. No. Area Number of patients Percentage
1. Rural 98 81.6%
2. Urban 12 10.8%

 

The incidence of cervical malignancy was significantly lower in Muslims (Table 4). This was in accordance with the study done by Wahi et al. [21] and Gajalakshmi and Shanta [19] that circumcision as practiced by Muslim could account for the lower incidence of cervical carcinoma as compared to Hindu community.

Table 4: Number of patients belonging to different religions.

S.No. Religion Number of patients Percentage
1. Hindu 107 89%
2. Muslim 3 2.5%
3. Sikhs 10 8%

 

The frequency of this malignancy was higher in women who were married between 21-25 years (Table 5). These findings were consistent with findings proposed by Misra et al. [12].

Table 5 Relationship of cervical cytopathologies with age at Marriage.

S.No Age at marriage Number of patients Percentage
1. 16-20 30 25%
2. 21-25 70 58.3%
3. 26-30 16 13.3%
4. 31-35 4 3.3%

 

62%of women had first issue at the age of 19-22 yrs (Table 6). This was in accordance with the study conducted by Dutta et al. [20] Thompson [22] and Varghese [23] that young age at first pregnancy is also a risk factor for CaCx.

 Table 6: Relationship of cervical cytopathologies with age at 1st Issue.

S.No. Age at marriage Number of patients Percentage
1. 16-19 34 28.33%
2. 19-22 66 55%
3. 22-25 10 8.33%
4. 25-30 11 9.1%

 

Chromosomal instability as manifested by increase in aneuploidy and structural chromosomal aberrations is believed to play a critical role in the intermediate to late stages in the development of cervical malignancies. Numerical chromosomal aberrations like aneuploidy and tetraploidy have earlier been reported in women diagnosed with precancerous and cancerous cervical lesions (Hesselmeyer et al. [24] Southern et al. [25] and Giannoudis et al. [26]). The presence of elevated levels of trisomy and aneusomy in the cervical carcinogenesis are consistent with the previous findings by various workers like Atkin et al. [27], Nguyen et al. [28] and Segers et al. [29].

Workers like Duensing et al. [30] and Skyldberg et al. [31] proposed that polyploidization of squamous cells seems to be a direct effect of HPV by inhibiting the formation of the mitotic apparatus in the prometaphase of the cell cycle. Centrosome disturbances occurring in the presence of episomal virus genome have been described as a possible mechanism of endoreduplication.

Chromosomal aberrations in cervical cancer have been extensively characterized by both classical and molecular cytogenetics. Chromosomes 3 and 17 have been reported to be frequently involved in squamous cell carcinoma (Kirchhoff et al. [32] and Hidalgo et al. [33]).

Besides chromosomal changes, micronuclei have also been recorded. The formation of MN in the dividing cells could be  the result of chromosomal breakage due to unrepaired or mis-repaired DNA lesions, or chromosome malsegregation due to mitotic malfunction. These events may be induced by oxidative stress, exposure to clastogens or aneugens, genetic defects in cell cycle checkpoint and/or DNA repair genes, as well as deficiencies in nutrients required as co-factors in DNA metabolism and chromosome segregation machinery (Kimura et al. [34], Umegaki. and Fenech, [35], Rajagopalan et al. [36], MacGregor, [37] and Fenech, [38].  All these events can cause the formation of MN through chromosomal rearrangements, altered gene expression or aneuploidy, effects associated with the chromosome instability phenotype often seen in cancer Rajagopalan et al.[39], Fenech [40] Fenech  et al.[41] and Ames and Wakimoto,  [42].

From the present study and the available literature it is evident that the chromosome analysis in different stages of carcinoma of the cervix provides an additional tool for the diagnosis of the carcinoma. The cytogenetic study if supplemented with molecular cytogenetic study especially Fluorescent in situ hybridization (FISH) will aid further in pinpointing the exact location of the gene/genes involved in the origin and progression of the tumor. The present work is therefore an addition to the existing literature on the cytogenetic study of the carcinoma of the cervix. The significance of chromosomal changes either in the origin of the tumor or in the progression of tumor is therefore debatable and more cytogenetic work needs to be carried out both by conventional and molecular cytogenetic techniques so as to find out the exact role of chromosomal changes in the origin and progression of carcinoma of cervix in particular and other carcinomas in general.

Acknowledgement

Authors are extremely thankful to the J&K State Council for Science and Technology, Department of Science and Technology, J & K State for providing financial support to conduct the research work.

References

  1. Matthews CP, Shera KA, McDougall JK. Genomic changes and HPV Type in Cervical carcinoma. Experimental Biology and Medicine 2000; 223:316-321.
  2. Murphy MU,  Turner M, Sheils O, O Leary JJ.P 16 INK4A as a marker for cervical dyskaryosis; CIN and GIN in cervical biopsies and Thin Prep TM smears.Journal clinical pathology 2003; 56:56-63
  3.  Bhattacharya N, Singh RK, Mondal S and Roy A, Panda CK. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients. Gynecologic Oncology 2004; 95: 352-362.
  4. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and Cervical Cancer statistics in India. 2007.
  5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999; 189: 12–19.
  6. Green J, Berrington G, Sweetland S, Beral V, Chilvers, Crossley B, Deacon J, Hermon C. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case- Control study of Cervical Cancer. British Journal of Cancer 2003; 89:2078-2086.
  7. Atkin NB, Baker MC. Chromosome 1 in 26 carcinomas of the cervix uteri. Cancer 1979; 44: 604-613.
  8. Seabright M. A rapid banding technique for Human Chromosomes. Lancet 1971; ii: 971-972.
  9. Spanos WJ, King A, Keeney E, Wagner R and Slater JM. Age as a prognostic factor in carcinoma of the cervix. Gynecol Oncol., 1989; 35: 66-68.
  10. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 1993; 54: 594–606.
  11. Miller AB. 1992. Cervical Cancer Screening Programmes: Managerial Guidelines. WHO, Geneva.
  12. Misra JS, Srivastava S, Singh U, Srivastava AN. Risk factors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Indian Journal of Cancer 2009; 46: 155-159.
  13. Wahi PN, Mali S, Luthra UK. Factors influencing cancer of the uterine cervix in North India. Cancer 1968; 23: 1221-1226.
  14. Brinton LA, Reeves WC, Brenes MM, Herrero R, Brinton R, Gaitan E, Tenorio, Garcia M , Rawls WE. Parity as a risk factor for cervical cancer. American Journal of Epidemiology 1989; 130: 486-496.
  15. Aras R, Pai NP. High fertility: risk factor for carcinoma cervix. The Journal of Family Welfare 1991; 41: 48-51.
  16.  Munoz N, Franceshi S, Bosetti C, Moreno V, Smith JS, Shah KV, Meijer CJ, Bosch F. Role of parity and Human papillomavirus in cervical cancer: the IARC multicentric case control study. Lancet 2002; 359: 1093-1101.
  17. Coker AL, Fang S, Eggleston KS. Socioeconomic status and cervical cancer survival among older women: Findings from the SEER- Medicine linked data cohorts. 2006.
  18. Gajalakshmi CK, Shanta V. Association between cervical and penile cancer in Madras, India. Gynecologic Oncology 2006; 102: 278-284.
  19. Dutta PK, Upadhya A, Dutta N, Urmil AC, Thergoakar MP, Ganguly SS.  A case control study of cervix cancer patients attending Command Hospital, Pune. Ind. J. Cancer 1990; 27: 101-8.
  20. Wahi PN, Luthra UK, Mali S, Mitra AB. Religion and cervical carcinoma in Agra. Indian Journal of Cancer 1972; 9: 210-25.
  21. Thompson JD. Cancer of cervix. In: Te Linde RW, Rock JA, Thompson JD, editors. Te Linde’s Operative Gynecology. Philadelphia: J B Lippincott Company 1992, 1162-3.
  22. Varghese PR. Protective effect of a traditional practice against cervix Cancer in Kerala. J. Hum. Ecol. 2004; 15: 187-190.
  23. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl Acad. Sci. USA 1996; 93: 479–484.
  24. Southern SA, Evans MF, Herrington,CS. Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses. Cancer Res 1997; 57: 4210–4213.
  25. Giannoudis A, Evans MF, Southern SA, Herrington CS. Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific. Br. J. Cancer 2000; 82:  424–428.
  26. Atkin NB, Baker MC, Fox MF. Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet. Cytogenet. 1990, 44: 229–241.
  27. Nguyen HN, Sevin BU, Averette HE, Ganjei P, Perras J, Ramos R, Angioli R, Donato D , Penalver M. The role of DNA index as a prognostic factor in early cervical carcinoma. Gynecol. Oncol 1993; 50:  54-59.
  28. Segers P, Haesen S, Castelian P, Amy JJ, De Sutter P, Van Dam P , Kirsch- Volders M. Study of numerical aberrations of chromosome 1 by fluorescent in situ hybridization and DNA content by denistometric analysis on (pre) malignant cervical lesions. Histochem. J 1995; 27:  315-324.
  29. Duensing S, Duensing A, Flores et al. Centrosome abnormality and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J. Virol 2001; 75: 7712-7716.
  30. Skyldberg B, Fujioka K, Hellstrom AC et al. Human papillomavirus infection, centrosome aberration and genetic instability in cervical lesions. Mod. Pathol 2001; 14: 279-284.
  31. Kirchhoff M, Rose H, Peterson BL, et al. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/ carcinoma in situ of the cervix and in the advanced stage cervical carcinoma. Genes Chromosomes Cancer 1999; 24: 144-150.
  32. Hidalgo A, Schewe C, Petreson BL et al. Human papillomavirus status and chromosomal imbalances in primary cervical carcinomas and tumor cell lines. Eur. J. Cancer 2000; 36: 542-548.
  33. Kimura M, Umegaki K, Higuchi M, Thomas P, Fenech M Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J. Nutr 2004; 134: 48–56
  34. Umegaki K and Fenech M.  Cytokinesis-block micronucleus assay in WIL2-NS cells: a sensitive system to detect chromosomal damage induced by reactive oxygen species and activated human neutrophils. Mutagenesis 2000; 15: 261–269.
  35. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C.. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428: 77–81.
  36. MacGregor JT. Dietary factors affecting spontaneous chromosomal damage in man. Prog. Clin. Biol. Res 1990; 347: 139–153.
  37. Fenech M., Baghurst P., Luderer W., Turner J., Record S., Ceppi M , Bonassi S. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, ß-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability—results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 2005; 26: 991–999.
  38. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 2003; 3: 695–701.
  39. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. Today 2002; 22: 1128–1137.
  40. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. HUMAN Project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res 2003; 534: 65–75.
  41. Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk?Nat.Rev.Cancer.2002,2:69
(Visited 136 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.